| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | MUC17 COL14A1 FRAS1 MXRA5 COL12A1 FN1 TNC LAMA4 TECTA EMILIN1 HMCN1 MUC2 | 1.09e-05 | 188 | 272 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | cadherin binding | PDXDC1 OBSCN CDH23 FNBP1L EHD4 PTPRH PLEC CNGA3 HSP90AB1 FLNA FLNB RARS1 EPCAM CDH8 CDH11 | 6.89e-05 | 339 | 272 | 15 | GO:0045296 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PDXDC1 ADAM9 OBSCN CDH23 FNBP1L CNTN6 EHD4 PTPRH PLEC CNGA3 HSP90AB1 FLNA FLNB RARS1 FN1 TNC EMILIN1 TENM1 EPCAM CDH8 CDH11 | 7.86e-05 | 599 | 272 | 21 | GO:0050839 |
| GeneOntologyMolecularFunction | mercury ion binding | 1.33e-04 | 8 | 272 | 3 | GO:0045340 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PSG6 CDH23 MDGA2 CNTN6 FAT1 FAT2 PTPRS ALCAM PCDH10 PCDHGA9 TGFB2 HMCN1 TENM1 CLDN5 EPCAM CDH8 CDH11 | 1.92e-07 | 313 | 271 | 18 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 ABL2 PSG6 ADAM9 CDH23 NCAM2 MDGA2 EXT1 CNTN6 FAT1 FAT2 STXBP1 PTPRS DLG2 COL14A1 LRRC7 ALCAM PCDH10 IL23R FLNA RC3H2 DOCK8 PCDHGA9 FNDC3A EMILIN1 TGFB2 DNAJA3 RHOH HMCN1 TENM1 CD274 CLDN5 TNF EPCAM CDH8 CDH11 | 2.57e-07 | 1077 | 271 | 36 | GO:0098609 |
| GeneOntologyBiologicalProcess | neuron development | ABL2 LRRK2 CDH23 NCAM2 EXT1 ZNF804A CNTN6 PTK6 STXBP1 PTPRS DLG2 LRRC7 FGFR3 ALCAM FGFR2 SLITRK6 MAP4K4 CNGA3 CUL4B SEMA4F FLNA FN1 TNC ARFGEF1 TECTA KIF3A TGFB2 RNF220 DZANK1 EFNA2 FEZ1 CAPRIN2 TENM1 TTL CNTN3 EIF2AK4 CDH11 VPS13B SEZ6 | 1.91e-05 | 1463 | 271 | 39 | GO:0048666 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PSG6 CDH23 CNTN6 FAT1 FAT2 PCDH10 PCDHGA9 HMCN1 CDH8 CDH11 | 3.89e-05 | 187 | 271 | 11 | GO:0007156 |
| GeneOntologyCellularComponent | side of membrane | PSG6 ADAM9 LRRK2 NCAM2 MDGA2 SPPL2B RYR2 CNTN6 MUC17 PRSS21 FGFR3 ALCAM DNAJA1 MMP19 TAPBP IL23R ADGRA3 IL31RA IDE TECTA LCT FCRL6 DNAJA3 EFNA2 CD274 CNTN3 TNF SERPINA5 | 1.00e-05 | 875 | 270 | 28 | GO:0098552 |
| GeneOntologyCellularComponent | axon | CNTNAP3B LRRK2 CNTNAP3 NCAM2 LMTK3 ZNF804A CNTN6 STXBP1 PTPRN PTPRS DLG2 LRRC7 ALCAM PLEC USH2A CNGA3 DYNC1H1 HSP90AB1 FLNA IL31RA PCLO KIF3A TGFB2 FEZ1 CLDN5 CDH8 | 9.74e-05 | 891 | 270 | 26 | GO:0030424 |
| GeneOntologyCellularComponent | perikaryon | CNTNAP3B CYP11A1 LRRK2 CNTNAP3 PTPRN PTPRS DLG2 CNGA3 SEMA4F FLNA EFNA2 | 1.62e-04 | 223 | 270 | 11 | GO:0043204 |
| GeneOntologyCellularComponent | cell body | CNTNAP3B CYP11A1 LRRK2 CNTNAP3 ZNF804A TXNRD1 PTPRN PTPRS DLG2 C4BPA ALCAM USH2A CNGA3 DYNC1H1 HSP90AB1 SEMA4F FLNA FLNB PCLO KIF3A TGFB2 EFNA2 FEZ1 TNF PACRG SEZ6 | 1.89e-04 | 929 | 270 | 26 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | CNTNAP3B CYP11A1 LRRK2 CNTNAP3 ZNF804A TXNRD1 PTPRN PTPRS DLG2 ALCAM USH2A CNGA3 DYNC1H1 HSP90AB1 SEMA4F FLNA FLNB PCLO KIF3A TGFB2 EFNA2 FEZ1 TNF SEZ6 | 2.27e-04 | 835 | 270 | 24 | GO:0043025 |
| GeneOntologyCellularComponent | anchoring collagen complex | 4.94e-04 | 3 | 270 | 2 | GO:0030934 | |
| Domain | - | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PIGR PTPRS ALPK3 COL14A1 FGFR3 ALCAM FGFR2 POGLUT2 USH2A TAPBP IL23R ADGRA3 FLNA FLNB IL31RA MXRA5 COL12A1 FN1 TNC FNDC3A FCRL6 TRIM45 HMCN1 CD274 CNTN3 | 8.48e-09 | 663 | 269 | 31 | 2.60.40.10 |
| Domain | Ig-like_fold | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PTPRH PIGR PTPRS ALPK3 COL14A1 FGFR3 ALCAM FGFR2 POGLUT2 USH2A TAPBP IL23R ADGRA3 FLNA FLNB IL31RA MXRA5 COL12A1 FN1 TNC FNDC3A FCRL6 TRIM45 HMCN1 CD274 CNTN3 | 1.00e-08 | 706 | 269 | 32 | IPR013783 |
| Domain | fn3 | OBSCN NCAM2 CNTN6 PTPRH PTPRS COL14A1 USH2A IL23R IL31RA COL12A1 FN1 TNC FNDC3A CNTN3 | 9.74e-08 | 162 | 269 | 14 | PF00041 |
| Domain | FN3 | OBSCN NCAM2 MDGA2 CNTN6 PTPRH PTPRS COL14A1 USH2A IL23R IL31RA COL12A1 FN1 TNC FNDC3A CNTN3 | 2.05e-07 | 199 | 269 | 15 | PS50853 |
| Domain | FN3_dom | OBSCN NCAM2 MDGA2 CNTN6 PTPRH PTPRS COL14A1 USH2A IL23R IL31RA COL12A1 FN1 TNC FNDC3A CNTN3 | 3.87e-07 | 209 | 269 | 15 | IPR003961 |
| Domain | FN3 | OBSCN NCAM2 CNTN6 PTPRH PTPRS COL14A1 USH2A IL23R IL31RA COL12A1 FN1 TNC FNDC3A CNTN3 | 5.01e-07 | 185 | 269 | 14 | SM00060 |
| Domain | IGc2 | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PTPRS ALPK3 FGFR3 ALCAM FGFR2 MXRA5 FCRL6 HMCN1 CNTN3 | 1.71e-06 | 235 | 269 | 15 | SM00408 |
| Domain | Ig_sub2 | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PTPRS ALPK3 FGFR3 ALCAM FGFR2 MXRA5 FCRL6 HMCN1 CNTN3 | 1.71e-06 | 235 | 269 | 15 | IPR003598 |
| Domain | Laminin_G | 1.72e-06 | 58 | 269 | 8 | IPR001791 | |
| Domain | EGF-like_dom | CNTNAP3B HGFAC ADAM9 CNTNAP3 FAT1 FAT2 MUC17 HYAL3 C8B FRAS1 TNC LAMA4 TECTA HMCN1 TENM1 | 3.48e-06 | 249 | 269 | 15 | IPR000742 |
| Domain | Ig_I-set | PDGFRL OBSCN NCAM2 MDGA2 CNTN6 PTPRS ALPK3 FGFR3 FGFR2 ADGRA3 MXRA5 HMCN1 CNTN3 | 3.96e-06 | 190 | 269 | 13 | IPR013098 |
| Domain | I-set | PDGFRL OBSCN NCAM2 MDGA2 CNTN6 PTPRS ALPK3 FGFR3 FGFR2 ADGRA3 MXRA5 HMCN1 CNTN3 | 3.96e-06 | 190 | 269 | 13 | PF07679 |
| Domain | EGF_1 | CNTNAP3B HGFAC ADAM9 CNTNAP3 FAT1 FAT2 MUC17 HYAL3 C8B USH2A FN1 TNC LAMA4 HMCN1 TENM1 | 4.66e-06 | 255 | 269 | 15 | PS00022 |
| Domain | IG_FLMN | 8.25e-06 | 10 | 269 | 4 | SM00557 | |
| Domain | EGF | CNTNAP3B HGFAC ADAM9 CNTNAP3 FAT1 FAT2 MUC17 HYAL3 FRAS1 TNC LAMA4 TECTA HMCN1 TENM1 | 8.40e-06 | 235 | 269 | 14 | SM00181 |
| Domain | Filamin | 1.28e-05 | 11 | 269 | 4 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.28e-05 | 11 | 269 | 4 | PS50194 | |
| Domain | Filamin/ABP280_repeat-like | 1.28e-05 | 11 | 269 | 4 | IPR017868 | |
| Domain | Filamin/ABP280_rpt | 1.28e-05 | 11 | 269 | 4 | IPR001298 | |
| Domain | LAM_G_DOMAIN | 1.58e-05 | 38 | 269 | 6 | PS50025 | |
| Domain | ig | PDGFRL PSG6 OBSCN NCAM2 MDGA2 PIGR PTPRS FGFR3 ALCAM ADGRA3 HMCN1 CNTN3 | 2.09e-05 | 190 | 269 | 12 | PF00047 |
| Domain | Immunoglobulin | PDGFRL PSG6 OBSCN NCAM2 MDGA2 PIGR PTPRS FGFR3 ALCAM ADGRA3 HMCN1 CNTN3 | 2.09e-05 | 190 | 269 | 12 | IPR013151 |
| Domain | Laminin_G_2 | 2.15e-05 | 40 | 269 | 6 | PF02210 | |
| Domain | LamG | 3.76e-05 | 44 | 269 | 6 | SM00282 | |
| Domain | IG | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PIGR PTPRS ALPK3 FGFR3 ALCAM FGFR2 ADGRA3 MXRA5 FCRL6 HMCN1 CD274 CNTN3 | 4.22e-05 | 421 | 269 | 18 | SM00409 |
| Domain | Ig_sub | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PIGR PTPRS ALPK3 FGFR3 ALCAM FGFR2 ADGRA3 MXRA5 FCRL6 HMCN1 CD274 CNTN3 | 4.22e-05 | 421 | 269 | 18 | IPR003599 |
| Domain | IG_LIKE | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PIGR PTPRS ALPK3 FGFR3 ALCAM FGFR2 TAPBP ADGRA3 MXRA5 FCRL6 HMCN1 CD274 CNTN3 | 9.80e-05 | 491 | 269 | 19 | PS50835 |
| Domain | EGF-like_CS | HGFAC ADAM9 CNTNAP3 FAT1 FAT2 MUC17 HYAL3 C8B FN1 TNC LAMA4 HMCN1 TENM1 | 1.12e-04 | 261 | 269 | 13 | IPR013032 |
| Domain | Ig-like_dom | PDGFRL PSG6 OBSCN NCAM2 MDGA2 CNTN6 PIGR PTPRS ALPK3 FGFR3 ALCAM FGFR2 TAPBP ADGRA3 MXRA5 FCRL6 HMCN1 CD274 CNTN3 | 1.34e-04 | 503 | 269 | 19 | IPR007110 |
| Domain | EGF_3 | CNTNAP3B HGFAC ADAM9 CNTNAP3 FAT1 FAT2 MUC17 HYAL3 C8B TNC HMCN1 TENM1 | 1.62e-04 | 235 | 269 | 12 | PS50026 |
| Domain | Cadherin_CS | 1.81e-04 | 109 | 269 | 8 | IPR020894 | |
| Domain | Secretoglobin_1C1/2 | 2.07e-04 | 2 | 269 | 2 | IPR028659 | |
| Domain | CADHERIN_1 | 2.32e-04 | 113 | 269 | 8 | PS00232 | |
| Domain | Cadherin | 2.32e-04 | 113 | 269 | 8 | PF00028 | |
| Domain | - | 2.46e-04 | 114 | 269 | 8 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 2.46e-04 | 114 | 269 | 8 | PS50268 | |
| Domain | CA | 2.61e-04 | 115 | 269 | 8 | SM00112 | |
| Domain | Cadherin-like | 2.77e-04 | 116 | 269 | 8 | IPR015919 | |
| Domain | Cadherin | 3.11e-04 | 118 | 269 | 8 | IPR002126 | |
| Domain | aa-tRNA-synt_IIb | 4.48e-04 | 11 | 269 | 3 | IPR002314 | |
| Domain | - | 4.48e-04 | 11 | 269 | 3 | 3.40.50.800 | |
| Domain | tRNA-synt_2b | 4.48e-04 | 11 | 269 | 3 | PF00587 | |
| Domain | EGF_2 | CNTNAP3B HGFAC ADAM9 CNTNAP3 FAT1 FAT2 MUC17 HYAL3 C8B TNC HMCN1 TENM1 | 4.85e-04 | 265 | 269 | 12 | PS01186 |
| Domain | Anticodon-bd | 9.56e-04 | 14 | 269 | 3 | IPR004154 | |
| Domain | Glycoside_hydrolase_SF | 9.75e-04 | 53 | 269 | 5 | IPR017853 | |
| Domain | FN1_2 | 1.22e-03 | 4 | 269 | 2 | PS51091 | |
| Domain | DnaJ_CXXCXGXG | 1.22e-03 | 4 | 269 | 2 | PF00684 | |
| Domain | - | 1.22e-03 | 4 | 269 | 2 | 2.10.230.10 | |
| Domain | Gal_mutarotase_N | 1.22e-03 | 4 | 269 | 2 | IPR031727 | |
| Domain | Fibronectin_type1 | 1.22e-03 | 4 | 269 | 2 | IPR000083 | |
| Domain | FN1 | 1.22e-03 | 4 | 269 | 2 | SM00058 | |
| Domain | Neural_cell_adh | 1.22e-03 | 4 | 269 | 2 | IPR009138 | |
| Domain | DnaJ | 1.22e-03 | 4 | 269 | 2 | IPR012724 | |
| Domain | ZF_CR | 1.22e-03 | 4 | 269 | 2 | PS51188 | |
| Domain | FGF_rcpt_fam | 1.22e-03 | 4 | 269 | 2 | IPR016248 | |
| Domain | fn1 | 1.22e-03 | 4 | 269 | 2 | PF00039 | |
| Domain | NtCtMGAM_N | 1.22e-03 | 4 | 269 | 2 | PF16863 | |
| Domain | FN1_1 | 1.22e-03 | 4 | 269 | 2 | PS01253 | |
| Domain | ConA-like_dom | CNTNAP3B CNTNAP3 MDGA2 RYR2 FAT1 FAT2 COL14A1 USH2A COL12A1 LAMA4 | 1.33e-03 | 219 | 269 | 10 | IPR013320 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GPR155 ATP6V1B2 ACLY ACY3 LRRK2 EHD4 FAT1 STXBP1 PIGR TMEM38A AP1M1 ALCAM C5 ALDH2 DNAJA1 DYNC1H1 CUL4B FLNA FLNB MXRA5 SLC5A10 RARS1 FN1 TMEM59 TECTA ABHD14B KIF3A GUSB EPCAM SERPINA5 GAA | 1.55e-10 | 1016 | 274 | 31 | 19056867 |
| Pubmed | HGFAC FAT2 PIGR PTPRS C4BPA ALCAM C5 C8B FN1 TNC PON1 SERPINA6 GUSB CNTN3 SERPINA5 GAA | 2.81e-10 | 257 | 274 | 16 | 16335952 | |
| Pubmed | PDXDC1 ATP6V1B2 ACLY ADAM9 UGGT1 URB2 FAT1 PRSS21 TMEM192 ERP29 POGLUT2 DNAJA1 HECTD1 TAPBP NUP160 DYNC1H1 HSP90AB1 FLNA FLNB COL12A1 RARS1 TMEM59 PRPF8 RING1 EDEM3 NCOR1 EEF1B2 LRPPRC GUSB LPL PES1 EIF5B HARS1 GAA | 9.88e-10 | 1297 | 274 | 34 | 33545068 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EMC4 ACLY ADAM9 UGGT1 CNTNAP3 ADGRG1 EXT1 FAT1 FKTN PTPRS XPO6 HYAL3 PRSS21 ERP29 ALCAM POGLUT2 HECTD1 TAPBP ADGRA3 SLC27A3 FRAS1 COL12A1 TMEM59 ARFGEF1 LAMA4 TGFB2 EDEM3 EEF1B2 GUSB LPL PES1 DCBLD2 | 2.17e-09 | 1201 | 274 | 32 | 35696571 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 RPL31 ACLY UGGT1 MRPS27 URB2 EHD4 ADSS2 UTP15 AP1M1 ERP29 ALDH2 DNAJA1 MAP4K4 NUP160 DYNC1H1 ADGRA3 MGAM2 HSP90AB1 FLII FLNA FLNB RARS1 PCLO NUP88 IDE NOL9 IDH3A PRPF8 DNAJA3 EEF1B2 LRPPRC PES1 EIF5B HARS1 | 2.96e-09 | 1425 | 274 | 35 | 30948266 |
| Pubmed | PDXDC1 ACLY UGGT1 HMGCS1 ACSL1 AP1M1 ALDH2 DNAJA1 NUP160 DYNC1H1 HSP90AB1 CUL4B FLII NUP88 NOL9 IDH3A PRPF8 DNAJA3 NCOR1 LRPPRC POLR3B | 4.87e-09 | 560 | 274 | 21 | 35241646 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 RPL31 SETD1B ACLY URB2 EHD4 ACSL1 ADSS2 UTP15 ZNF638 AP1M1 ERP29 PLEC DNAJA1 NUP160 DYNC1H1 HSP90AB1 FLII FLNA FLNB RARS1 FN1 NOL9 PRPF8 ABHD14B RING1 DNAJA3 EEF1B2 LRPPRC EIF2D POLR3B PES1 EIF5B | 1.03e-08 | 1353 | 274 | 33 | 29467282 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 ATP6V1B2 RPL31 UBE2K ZNF804A EHD4 AP1M1 LRRC7 PLEC DNAJA1 MAP4K4 DYNC1H1 HSP90AB1 HSP90AB3P CUL4B FLNA FLNB RARS1 PARP3 IDE IDH3A PRPF8 EEF1B2 POLR3B HARS1 | 1.96e-08 | 847 | 274 | 25 | 35235311 |
| Pubmed | ACLY UGGT1 URB2 UTP15 ZNF638 PLEC DNAJA1 HECTD1 NUP160 DYNC1H1 CUL4B FLNA FLNB FN1 NUP88 NOL9 PRPF8 LRPPRC PES1 EIF5B XPO7 | 6.76e-08 | 653 | 274 | 21 | 22586326 | |
| Pubmed | EPRS1 KCNH7 EMC4 MRPS27 HMGCS1 RYR2 STXBP1 AP1M1 DLG2 LRRC7 PLEC DNAJA1 MAP4K4 HSP90AB1 FLII FLNA FLNB RARS1 PCLO NUP88 IDH3A DNAJA3 EEF1B2 DZANK1 LRPPRC CADPS TENM1 FAM177A1 | 1.25e-07 | 1139 | 274 | 28 | 36417873 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 EPRS1 EMC4 ACLY ADAM9 URB2 XPO6 DNAJA1 HECTD1 TAPBP DYNC1H1 SLC27A3 HSP90AB1 FLNA RARS1 TMEM59 NUP88 ARFGEF1 FNDC3A DHRS7B LRPPRC PES1 TNF GAA XPO7 | 1.49e-07 | 942 | 274 | 25 | 31073040 |
| Pubmed | EFCAB5 EPRS1 UGGT1 ASH1L FNBP1L RYR2 EHD4 STXBP1 DLG2 ALCAM ALDH2 PLEC METTL25 DNAJA1 HSP90AB1 FLNA FLNB PCDHGA9 PCLO PRPF8 DHRS7B RING1 ADAMTS12 NCOR1 EEF1B2 LRPPRC SUGCT PES1 CAPRIN2 TENM1 EIF5B EIF2AK4 | 1.52e-07 | 1442 | 274 | 32 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 ATP6V1B2 ACLY UGGT1 URB2 EHD4 ZNF638 PLEC DNAJA1 MAP4K4 NUP160 DYNC1H1 HSP90AB1 FLII FLNA FLNB RARS1 TMEM59 IDH3A PRPF8 EEF1B2 LRPPRC SLC20A1 PES1 EIF5B XPO7 | 1.95e-07 | 1024 | 274 | 26 | 24711643 |
| Pubmed | PDXDC1 EPRS1 RPL31 ACLY AP1M1 PLEC DNAJA1 HECTD1 NUP160 DYNC1H1 HSP90AB1 CUL4B FLNA FLNB RARS1 IDH3A PRPF8 LRPPRC PES1 EIF5B | 2.10e-07 | 638 | 274 | 20 | 33239621 | |
| Pubmed | 3.03e-07 | 35 | 274 | 6 | 15031101 | ||
| Pubmed | EPRS1 ATP6V1B2 ACLY TMEM192 ALCAM DNAJA1 NUP160 DYNC1H1 HSP90AB1 FLNA FLNB RARS1 NUP88 NOL9 PRPF8 DNAJA3 EEF1B2 | 3.69e-07 | 484 | 274 | 17 | 31995728 | |
| Pubmed | NLRP11 EFCAB5 ACLY FAT2 PLEC HSP90AB1 FLNA FLNB PRPF8 EEF1B2 PES1 VPS13B | 4.04e-07 | 234 | 274 | 12 | 36243803 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | EPRS1 ATP6V1B2 PCNX3 MRPS27 EHD4 UTP15 ZNF638 C5 ALDH2 DNAJA1 TARBP2 HSP90AB3P RARS1 NMNAT1 IDE PRPF8 EEF1B2 AGO1 PES1 EIF5B HARS1 | 4.42e-07 | 732 | 274 | 21 | 34732716 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ATP6V1B2 ACLY ADAM9 ADGRG1 EHD4 ADSS2 PIGR PTPRS C5 C8B DYNC1H1 HSP90AB1 HSP90AB3P FLNA FLNB SLC5A10 FN1 GPX3 PON1 SERPINA6 ABHD14B HMCN1 GUSB SERPINA5 CDH11 GAA | 4.49e-07 | 1070 | 274 | 26 | 23533145 |
| Pubmed | OBSCN RYR2 EHD4 ACSL1 FSIP2 ALDH2 PLEC DYNC1H1 HSP90AB1 FN1 IDH3A DNAJA3 LRPPRC VPS13B | 4.54e-07 | 331 | 274 | 14 | 29199018 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PDXDC1 EPRS1 RPL31 ACLY UGGT1 ASH1L TXNRD1 ADSS2 ERP29 PLEC DYNC1H1 HSP90AB1 FLNA FLNB RARS1 PCLO PRPF8 DNAH1 EEF1B2 LRPPRC EIF5B HARS1 | 5.49e-07 | 807 | 274 | 22 | 30575818 |
| Pubmed | PDXDC1 EFCAB5 EPRS1 ATP6V1B2 ACLY HMGCS1 HMCES ADSS2 ALDH2 DYNC1H1 HSP90AB1 CUL4B FLNA FLNB RARS1 NUP88 IDH3A PRPF8 ABHD14B EEF1B2 LRPPRC PES1 HARS1 | 5.98e-07 | 878 | 274 | 23 | 37223481 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 6.47e-07 | 91 | 274 | 8 | 28558017 | |
| Pubmed | 7.39e-07 | 64 | 274 | 7 | 22261194 | ||
| Pubmed | 9.33e-07 | 167 | 274 | 10 | 22159717 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TPRA1 UBE2K SGSM1 ERV3-1 ASH1L OBSCN ADGRG1 NCAM2 FNBP1L SPPL2B PTK6 PLEKHH1 PTPRS SHPRH ZNF638 LRRC7 ALCAM HECTD1 FLNB PRR5 IDE TECTA DHRS7B DNAH1 OR51E2 LRPPRC THRA EIF2AK4 PACRG VPS13B XPO7 | 9.36e-07 | 1489 | 274 | 31 | 28611215 |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 1.80e-06 | 104 | 274 | 8 | 36055981 | |
| Pubmed | EPRS1 GSDME XPO6 AP1M1 DNAJA1 HSP90AB1 RARS1 ARFGEF1 DNAJA3 XPO7 | 2.14e-06 | 183 | 274 | 10 | 23956138 | |
| Pubmed | 2.31e-06 | 144 | 274 | 9 | 35681168 | ||
| Pubmed | OBSCN GSDME COL14A1 PLEC HSP90AB1 FLNB AMPD1 COL12A1 NRAP FN1 LAMA4 KIF3A DNAJA3 NCOR1 LRPPRC THRA | 2.52e-06 | 497 | 274 | 16 | 23414517 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | ATP6V1B2 UBE2K ACLY TXNRD1 FSIP2 STXBP1 ERP29 ALDH2 DNAJA1 MAP4K4 DYNC1H1 HSP90AB1 FLNA EEF1B2 AGO1 CADPS EIF5B | 2.56e-06 | 558 | 274 | 17 | 35063084 |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 2.62e-06 | 77 | 274 | 7 | 16944957 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 EHD4 ZNF638 PLEC DNAJA1 NUP160 DYNC1H1 HSP90AB1 FLNA FLNB RARS1 PRPF8 NCOR1 | 2.75e-06 | 332 | 274 | 13 | 32786267 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 RPL31 ACLY UGGT1 MRPS27 UTP15 ZNF638 AP1M1 PLEC DNAJA1 NUP160 DYNC1H1 HSP90AB1 FLII FLNA FLNB RARS1 NMNAT1 NOL9 PRPF8 DHRS7B DNAJA3 EEF1B2 LRPPRC PES1 EIF5B GATAD1 | 2.78e-06 | 1257 | 274 | 27 | 36526897 |
| Pubmed | EPRS1 ATP6V1B2 RPL31 IL16 ACLY NCAM2 STXBP1 PTPRS DLG2 LRRC7 ALDH2 PLEC SLC25A23 DYNC1H1 HSP90AB1 FLII FLNA FLNB FN1 DOCK8 TNC PCLO IDH3A KIF3A EEF1B2 DZANK1 LRPPRC AGO1 CADPS | 3.63e-06 | 1431 | 274 | 29 | 37142655 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | EPRS1 RPL31 ACLY MRPS27 AP1M1 DNAJA1 DYNC1H1 HSP90AB1 HSP90AB3P FLNA RARS1 NCOR1 LRPPRC | 4.05e-06 | 344 | 274 | 13 | 36282215 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDXDC1 EPRS1 RPL31 UBE2K ACLY UGGT1 EXT1 SMYD2 C2CD5 EHD4 PIGR PTPRS XPO6 LRRC7 DNAJA1 NUP160 DYNC1H1 RARS1 FNTB PARP3 PRPF8 AZIN1 EEF1B2 LRPPRC EIF2D PES1 XPO7 | 4.11e-06 | 1284 | 274 | 27 | 17353931 |
| Pubmed | EPRS1 ATP6V1B2 DCHS2 ADAM9 ASH1L NCAM2 SMYD2 PLEKHH1 STXBP1 DLG2 PLEC DNAJA1 HECTD1 MAP4K4 DYNC1H1 HSP90AB1 FLII FLNB FN1 TMEM59 PRPF8 KIF3A RNF220 POLR3B FEZ1 CADPS HARS1 | 4.17e-06 | 1285 | 274 | 27 | 35914814 | |
| Pubmed | PDXDC1 EPRS1 SETD1B MRPS27 FNBP1L PLEC DYNC1H1 HSP90AB1 FLII FLNA FLNB RARS1 FN1 IDH3A PRPF8 RING1 DNAJA3 EEF1B2 LRPPRC | 4.42e-06 | 711 | 274 | 19 | 33022573 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL31 UBE2K UGGT1 HMGCS1 FNBP1L EHD4 TXNRD1 ADSS2 UTP15 AP1M1 ALCAM DNAJA1 NUP160 HSP90AB1 FLNA FLNB AMPD1 ARFGEF1 IDE NOL9 IDH3A PRPF8 EEF1B2 LRPPRC SLC20A1 EIF5B GAA XPO7 | 4.43e-06 | 1367 | 274 | 28 | 32687490 |
| Pubmed | ATP6V1B2 ABL2 NCAM2 FNBP1L LMTK3 C2CD5 STXBP1 DLG2 LRRC7 PLEC HSP90AB1 TNC PCLO | 4.44e-06 | 347 | 274 | 13 | 17114649 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | PDXDC1 EPRS1 RPL31 EMC4 ACLY UGGT1 EXT1 TMEM11 ACSL1 FAT1 ALDH2 PLEC POGLUT2 MAP4K4 TAPBP SLC27A3 HSP90AB1 FLNA FLNB APOO FN1 IDH3A PRPF8 DHRS7B DNAJA3 LRPPRC GUSB GAA XPO7 | 4.74e-06 | 1451 | 274 | 29 | 30550785 |
| Pubmed | 4.78e-06 | 5 | 274 | 3 | 17001213 | ||
| Pubmed | 4.80e-06 | 15 | 274 | 4 | 17400507 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.16e-06 | 202 | 274 | 10 | 33005030 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 RPL31 ACLY UGGT1 MRPS27 HMGCS1 PHKA2 ERP29 PLEC DNAJA1 DYNC1H1 HSP90AB1 FLII FLNA FLNB RARS1 FNTB NOL9 IDH3A PRPF8 DNAJA3 EEF1B2 LRPPRC EIF5B HARS1 | 5.30e-06 | 1149 | 274 | 25 | 35446349 |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.51e-06 | 86 | 274 | 7 | 28327460 | |
| Pubmed | 6.06e-06 | 162 | 274 | 9 | 25826454 | ||
| Pubmed | EPRS1 RPL31 AP1M1 PLEC DNAJA1 MAP4K4 DYNC1H1 CUL4B FLII FLNA RARS1 PRPF8 EEF1B2 LRPPRC PES1 EIF5B EIF2AK4 | 6.82e-06 | 601 | 274 | 17 | 33658012 | |
| Pubmed | EPRS1 RPL31 UGGT1 PIGR ERP29 DNAJA1 HSP90AB1 RARS1 TNC TMEM59 EMILIN1 DNAJA3 LRPPRC EIF5B | 6.89e-06 | 418 | 274 | 14 | 35338135 | |
| Pubmed | EPRS1 ATP6V1B2 RPL31 ACLY EHD4 PLEC DNAJA1 TAPBP NUP160 DYNC1H1 HSP90AB1 CUL4B FLNA FLNB DPP10 RARS1 PRPF8 EEF1B2 LRPPRC PES1 | 6.99e-06 | 803 | 274 | 20 | 36517590 | |
| Pubmed | ABL2 SETD1B ASH1L CDH23 LMTK3 PHKA2 FGFR3 FGFR2 ALDH2 CUL4B TECTA | 7.02e-06 | 257 | 274 | 11 | 30945288 | |
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 7.19e-06 | 59 | 274 | 6 | 17330941 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 SGSM1 ACLY OBSCN ANKRD20A3P LRRC7 MTARC2 DNAJA1 PCDH10 DYNC1H1 HSP90AB1 SEMA4F FLNB MXRA5 RARS1 FN1 PCLO PRPF8 RBM43 | 7.21e-06 | 736 | 274 | 19 | 29676528 |
| Pubmed | Vector-capping: a simple method for preparing a high-quality full-length cDNA library. | 9.51e-06 | 6 | 274 | 3 | 16106752 | |
| Pubmed | 9.51e-06 | 6 | 274 | 3 | 17428620 | ||
| Pubmed | Discrete domains of gene expression in germinal layers distinguish the development of gyrencephaly. | 9.51e-06 | 6 | 274 | 3 | 25916825 | |
| Pubmed | 1.03e-05 | 173 | 274 | 9 | 23979707 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | EPRS1 ACLY PLEC TAPBP DYNC1H1 HSP90AB1 FLII FLNA FLNB RARS1 PRPF8 | 1.04e-05 | 268 | 274 | 11 | 33024031 |
| Pubmed | EPRS1 RPL31 ACLY UGGT1 PLEC DNAJA1 NUP160 HSP90AB1 FLII FLNA FLNB RARS1 ARFGEF1 EEF1B2 EIF5B | 1.04e-05 | 494 | 274 | 15 | 26831064 | |
| Pubmed | ADGRG1 HMGCS1 FNBP1L ZNF804A PTPRN ALCAM DPP10 TNC CADPS CLDN5 CDH11 GAA SEZ6 | 1.05e-05 | 376 | 274 | 13 | 24154525 | |
| Pubmed | APEX2 PLEC DNAJA1 MGAM2 NMNAT1 PCLO EMILIN1 DNAH1 TGFB2 DNAJA3 ZNF12 AGO1 CADPS PES1 EIF5B | 1.09e-05 | 496 | 274 | 15 | 31343991 | |
| Pubmed | PDXDC1 EHD4 UTP15 AP1M1 DNAJA1 CUL4B IDH3A DHRS7B DNAJA3 EEF1B2 LRPPRC XPO7 | 1.13e-05 | 323 | 274 | 12 | 24797263 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | EPRS1 ACLY DNAJA1 DYNC1H1 HSP90AB1 HSP90AB3P FLNA RARS1 LRPPRC | 1.13e-05 | 175 | 274 | 9 | 25756610 |
| Pubmed | Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth. | 1.33e-05 | 19 | 274 | 4 | 37541847 | |
| Pubmed | EPRS1 ACLY UGGT1 MRPS27 SHC3 COL14A1 ERP29 C5 PLEC TARBP2 DYNC1H1 HSP90AB1 FLII FLNA RC3H2 A1CF RARS1 FN1 NMNAT1 NOL9 PRPF8 ABHD14B RING1 PES1 EIF2AK4 HARS1 SERPINA5 | 1.33e-05 | 1371 | 274 | 27 | 36244648 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 EPRS1 ATP6V1B2 ACLY UGGT1 EHD4 TXNRD1 ADSS2 AP1M1 PLEC DNAJA1 HECTD1 NUP160 DYNC1H1 HSP90AB1 CUL4B FLII FLNA FLNB RARS1 FNTB NUP88 IDE EEF1B2 PES1 EIF5B HARS1 XPO7 | 1.39e-05 | 1455 | 274 | 28 | 22863883 |
| Pubmed | ABL2 URB2 FAT1 FGFR3 PLEC DYNC1H1 HSP90AB1 FLNA FLNB RC3H2 PRPF8 NUDT6 | 1.48e-05 | 332 | 274 | 12 | 37433992 | |
| Pubmed | Sall1 balances self-renewal and differentiation of renal progenitor cells. | 1.51e-05 | 67 | 274 | 6 | 24550112 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | EPRS1 ACLY DNAJA1 DYNC1H1 HSP90AB1 FLNA RARS1 LAMA4 PRPF8 DNAJA3 EEF1B2 | 1.62e-05 | 281 | 274 | 11 | 30455355 |
| Pubmed | 1.65e-05 | 7 | 274 | 3 | 16059920 | ||
| Pubmed | 1.65e-05 | 7 | 274 | 3 | 23525008 | ||
| Pubmed | EPRS1 HGFAC ATP6V1B2 EMC4 ACLY OBSCN MRPS27 HMGCS1 TXNRD1 STXBP1 AP1M1 ERP29 ALCAM ALDH2 HSP90AB1 RARS1 LAMA4 IDH3A EEF1B2 LRPPRC | 1.85e-05 | 859 | 274 | 20 | 31536960 | |
| Pubmed | ATP6V1B2 EMC4 UGGT1 MRPS27 C2CD5 EHD4 UTP15 CCDC138 COL14A1 ERP29 ALDH2 DNAJA1 MAP4K4 TARBP2 FRAS1 TMEM59 FNDC3A NOL9 PRPF8 DNAJA3 LRPPRC GUSB SLC20A1 PPP1R15B PES1 EIF5B VPS13B FAM177A1 | 2.06e-05 | 1487 | 274 | 28 | 33957083 | |
| Pubmed | EPRS1 RPL31 ACLY EHD4 ACSL1 AP1M1 ERP29 DNAJA1 DYNC1H1 SLC27A3 HSP90AB1 FLNA RARS1 DOCK8 FNDC3A NOL9 PRPF8 DHRS7B NCOR1 LRPPRC GUSB PES1 ARHGAP45 GAA | 2.09e-05 | 1168 | 274 | 24 | 19946888 | |
| Pubmed | EPRS1 RPL31 UGGT1 MRPS27 DNAJA1 DYNC1H1 HSP90AB1 FLNA AMPD1 RARS1 PRPF8 DHRS7B DNAJA3 EEF1B2 LRPPRC PES1 EIF5B HARS1 | 2.11e-05 | 725 | 274 | 18 | 27025967 | |
| Pubmed | SETD1B ADAM9 URB2 SLC25A25 PLEKHH1 RHOBTB2 LRRC7 PCDH10 DYNC1H1 FRAS1 CADPS VPS13B XPO7 | 2.41e-05 | 407 | 274 | 13 | 12693553 | |
| Pubmed | 2.47e-05 | 22 | 274 | 4 | 27527664 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TPRA1 SETD1B PCNX3 OBSCN SPPL2B FAT1 PTPRS XPO6 FGFR2 PLEC HECTD1 DYNC1H1 SEMA4F FLII FLNA FRAS1 ARSJ FNTB NCOR1 EFNA2 TRIB3 PPP1R15B PAXIP1 | 2.56e-05 | 1105 | 274 | 23 | 35748872 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 2.63e-05 | 8 | 274 | 3 | 12634303 | |
| Pubmed | 2.63e-05 | 8 | 274 | 3 | 19818126 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | CATSPERE ABL2 ASH1L OBSCN FNBP1L SMYD2 LRRC7 MTARC2 C8B USH2A IL23R SLC27A3 AMPD1 TMEM59 NOL9 FCRL6 APOBEC4 TRIM45 EDEM3 RNF220 AGO1 HMCN1 | 2.66e-05 | 1031 | 274 | 22 | 16710414 |
| Pubmed | 2.78e-05 | 110 | 274 | 7 | 25940091 | ||
| Pubmed | 2.89e-05 | 197 | 274 | 9 | 31620119 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | ADAM9 COL14A1 MMP19 COL12A1 FN1 TNC GPX3 LAMA4 EMILIN1 TGFB2 | 3.05e-05 | 248 | 274 | 10 | 24006456 |
| Pubmed | RPL31 URB2 PIGR UTP15 ZNF638 DNAJA1 DYNC1H1 FLNA RARS1 NOL9 PRPF8 DNAJA3 PES1 EIF5B | 3.41e-05 | 483 | 274 | 14 | 36912080 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDXDC1 ACLY UGGT1 MRPS27 C2CD5 ACSL1 PTPRH PTPRS TMEM192 HECTD1 NUP160 SLC27A3 HSP90AB3P FLNA FLNB FNTB NUP88 IDE PRPF8 EEF1B2 LRPPRC | 3.50e-05 | 974 | 274 | 21 | 28675297 |
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 3.54e-05 | 24 | 274 | 4 | 26116661 | |
| Pubmed | 3.80e-05 | 48 | 274 | 5 | 22359512 | ||
| Pubmed | RPL31 PCNX3 LRRK2 ASH1L OBSCN HMCES GALNT13 CNTN6 FAT1 RHOBTB1 PTPRS COL14A1 FGFR2 NUP160 NOVA1 EMILIN1 AZIN1 RNF220 FEZ1 TENM1 TTL GATAD1 EIF2AK4 ARHGAP45 | 3.91e-05 | 1215 | 274 | 24 | 15146197 | |
| Pubmed | 3.92e-05 | 9 | 274 | 3 | 9882526 | ||
| Pubmed | 3.92e-05 | 9 | 274 | 3 | 15229180 | ||
| Pubmed | Nucleolar localization of human methionyl-tRNA synthetase and its role in ribosomal RNA synthesis. | 3.92e-05 | 9 | 274 | 3 | 10791971 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CNTNAP3B VPS11 EMC4 ADAM9 CNTNAP3 ADGRG1 EXT1 FAT1 PTPRS TMEM192 C5 ALDH2 TARBP2 ADGRA3 NOVA1 IL31RA ARFGEF1 TGFB2 GUSB SLC20A1 EPCAM DCBLD2 | 4.07e-05 | 1061 | 274 | 22 | 33845483 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | RPL31 UBE2K ACLY ZNF638 ERP29 DNAJA1 NUP160 RNF138 HSP90AB1 FLII NUP88 PRPF8 NCOR1 EEF1B2 EIF2D PES1 | 4.16e-05 | 624 | 274 | 16 | 33729478 |
| Pubmed | 4.20e-05 | 49 | 274 | 5 | 21362503 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | ACLY UGGT1 TXNRD1 RHOBTB1 ADSS2 DNAJA1 RNF138 HSP90AB1 CUL4B FLNA FLNB RARS1 EEF1B2 LRPPRC | 4.45e-05 | 495 | 274 | 14 | 28581483 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 OBSCN MRPS27 AK9 TTC6 APEX2 SHPRH MMP19 MAP4K4 TAPBP FLII FN1 PRPF8 EIF2AK4 | 4.64e-05 | 497 | 274 | 14 | 36774506 |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | CYP11A1 ACLY MRPS27 SLC25A25 PTGR3 TXNRD1 TMEM11 ACSL1 FSIP2 PRODH2 MTARC2 ALDH2 SLC25A23 RARS1 IDE IDH3A DNAJA3 LRPPRC SUGCT PACRG | 5.27e-05 | 926 | 274 | 20 | 20877624 |
| Pubmed | Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. | 5.57e-05 | 10 | 274 | 3 | 19826009 | |
| Interaction | CBLN4 interactions | CNTNAP3B PDGFRL ADAM9 CNTNAP3 ADGRG1 FGFR3 POGLUT2 FRAS1 TMEM59 EDEM3 GUSB | 1.19e-06 | 127 | 271 | 11 | int:CBLN4 |
| Interaction | STIP1 interactions | PDXDC1 EPRS1 ATP6V1B2 RPL31 EMC4 ACLY LRRK2 SMYD2 TXNRD1 ADSS2 AP1M1 PLEC DNAJA1 HECTD1 NUP160 DYNC1H1 HSP90AB1 HSP90AB3P CUL4B FLNA FLNB RARS1 FN1 DOCK8 POT1 IDH3A PRPF8 TIPARP LRPPRC PES1 EIF5B CD274 PACRG | 2.12e-06 | 1006 | 271 | 33 | int:STIP1 |
| Interaction | FBXO2 interactions | CNTNAP3B EMC4 ADAM9 CNTNAP3 ADGRG1 PTPRS COL14A1 FGFR3 ALCAM FGFR2 TAPBP ADGRA3 FRAS1 COL12A1 FN1 LAMA4 GUSB SERPINA5 GAA | 3.32e-06 | 411 | 271 | 19 | int:FBXO2 |
| Interaction | PDIA3 interactions | ACLY LRRK2 FSIP2 ADSS2 PTPRH PTPRN PLEC DNAJA1 TAPBP HSP90AB1 CUL4B FLNA COL12A1 DOCK8 ARFGEF1 PRPF8 EDEM3 PES1 EIF5B CD274 | 7.61e-06 | 476 | 271 | 20 | int:PDIA3 |
| Interaction | NUDC interactions | EPRS1 DCDC1 ACLY ADAM9 LRRK2 AP1M1 DNAJA1 DYNC1H1 HSP90AB1 FLNB RARS1 POT1 FNDC3A PRPF8 TIPARP HARS1 | 1.44e-05 | 337 | 271 | 16 | int:NUDC |
| GeneFamily | Fibronectin type III domain containing | OBSCN NCAM2 CNTN6 PTPRH PTPRS COL14A1 USH2A IL31RA COL12A1 FN1 TNC FNDC3A CNTN3 | 2.09e-08 | 160 | 196 | 13 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PDGFRL OBSCN NCAM2 MDGA2 CNTN6 PTPRS ALPK3 FGFR3 FGFR2 ADGRA3 MXRA5 HMCN1 CNTN3 | 2.25e-08 | 161 | 196 | 13 | 593 |
| GeneFamily | Cadherin related | 2.85e-05 | 17 | 196 | 4 | 24 | |
| GeneFamily | Rho family GTPases | 1.25e-03 | 20 | 196 | 3 | 390 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.44e-03 | 21 | 196 | 3 | 813 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | SGSM1 ADGRG1 CHN2 ACSL1 STXBP1 PTPRN SLITRK6 COL12A1 DPP10 PCLO GPX3 RFX6 GPR160 CADPS CLDN5 | 1.55e-07 | 268 | 272 | 15 | M45696 |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | ACLY UGGT1 MRPS27 HMGCS1 FNBP1L SMYD2 RHOBTB1 ALCAM MAP4K4 HSP90AB1 RC3H2 PRR15L EPCAM | 3.95e-07 | 213 | 272 | 13 | M14601 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | KCNH7 SHC3 FAT2 PTPRH PIGR PTPRN HYAL3 DLG2 LRRC7 MTARC2 C8B CNGA3 AMPD1 FNTB DOCK8 TNC PON1 IDE LCT DHRS7B DNAH1 OR51E2 NUDT6 FEZ1 LPL EIF5B TNF MUC2 EPCAM CDH8 ATP4B SERPINA5 | 4.22e-06 | 1281 | 272 | 32 | M1884 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | ADAM9 UGGT1 RHOBTB1 MAP4K4 DYNC1H1 COL12A1 TNC LAMA4 TGFB2 CDH11 | 7.95e-06 | 162 | 272 | 10 | M45037 |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP | PDXDC1 GPR155 EPRS1 TPRA1 CDH23 SMYD2 PHKA2 PLEC PCLO EMILIN1 SLC20A1 | 8.06e-06 | 199 | 272 | 11 | M3972 |
| Coexpression | BOQUEST_STEM_CELL_UP | PLBD1 PDGFRL FAT1 COL14A1 NOVA1 MXRA5 TNC TGFB2 FEZ1 TENM1 SERPINA5 CDH11 | 2.01e-05 | 261 | 272 | 12 | M1834 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 2.43e-05 | 17 | 272 | 4 | M47995 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 2.92e-05 | 35 | 272 | 5 | MM17054 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL | 3.67e-05 | 155 | 272 | 9 | M45695 | |
| Coexpression | FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP | 4.30e-05 | 90 | 272 | 7 | M48360 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 4.62e-05 | 91 | 272 | 7 | M40180 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP | PLBD1 TPRA1 IL16 CYP11A1 ADAM9 PAN2 TARBP2 SEMA4F SLC2A8 GPX3 | 4.90e-05 | 200 | 272 | 10 | M8596 |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN | TMEM128 PTGR3 ADSS2 SLC35E3 CUL4B CCNQ TIPARP EEF1B2 RHOH TRIB3 | 4.90e-05 | 200 | 272 | 10 | M7884 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | ACLY ADGRG1 ACSL1 TAPBP DYNC1H1 FLII FLNA FLNB FRAS1 FN1 PRPF8 ABHD14B GATAD1 EPCAM GAA | 5.27e-05 | 433 | 272 | 15 | M2240 |
| Coexpression | AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP | 5.30e-05 | 126 | 272 | 8 | M2309 | |
| Coexpression | ACEVEDO_LIVER_CANCER_DN | HGFAC ATP6V1B2 HMGCS1 PHKA2 PRODH2 C5 ALDH2 DNAJA1 SLC25A23 DYNC1H1 MXRA5 PON1 SERPINA6 TRIB3 SLC20A1 ALKBH3 SERPINA5 | 5.55e-05 | 540 | 272 | 17 | M7577 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_200 | 1.28e-05 | 62 | 268 | 7 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | ABL2 URB2 C2CD5 METTL25 POT1 NUP88 IDE NOL9 DNAJA3 EEF1B2 LRPPRC POLR3B EPCAM | 1.40e-05 | 243 | 268 | 13 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | UBE2K KLHL28 NCAM2 ZNF804A RYR2 SHPRH COL14A1 SLITRK6 PCDH10 NOVA1 SEMA4F DPP10 TGFB2 OR51E2 CADPS TENM1 CNTN3 | 3.32e-05 | 427 | 268 | 17 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN NCAM2 MDGA2 GALNT13 RYR2 FAT1 USH2A PCDH10 FRAS1 COL12A1 PCLO DNAH1 HMCN1 TENM1 | 9.69e-12 | 184 | 274 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN NCAM2 MDGA2 GALNT13 RYR2 FAT1 USH2A PCDH10 FRAS1 COL12A1 PCLO DNAH1 HMCN1 TENM1 | 9.69e-12 | 184 | 274 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN NCAM2 MDGA2 GALNT13 RYR2 FAT1 USH2A PCDH10 FRAS1 COL12A1 PCLO DNAH1 HMCN1 TENM1 | 9.69e-12 | 184 | 274 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | NCAM2 RYR2 DLG2 COL14A1 MXRA5 COL12A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 SUGCT CDH11 | 2.43e-11 | 197 | 274 | 14 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | IL16 CDH23 NCAM2 RYR2 DLG2 MMP19 FN1 TNC EMILIN1 ADAMTS12 HMCN1 SUGCT CDH11 VPS13B | 2.43e-11 | 197 | 274 | 14 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | CDH23 NCAM2 RYR2 PTPRS FN1 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 FEZ1 CDH11 | 1.67e-10 | 187 | 274 | 13 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | NCAM2 RYR2 PTPRS DLG2 COL14A1 FRAS1 FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 3.38e-10 | 198 | 274 | 13 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | IL16 CDH23 NCAM2 RYR2 PTPRS COL14A1 FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 3.38e-10 | 198 | 274 | 13 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL14A1 FGFR2 SLITRK6 NOVA1 FLNB MXRA5 COL12A1 FN1 TNC GPX3 LAMA4 EMILIN1 CDH11 | 3.60e-10 | 199 | 274 | 13 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MDGA2 CNTN6 LRRC7 USH2A FRAS1 A1CF DPP10 TECTA SERPINA6 TENM1 CNTN3 | 1.72e-09 | 145 | 274 | 11 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 |
| ToppCell | 15-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | ADGRG1 CHN2 GALNT13 TTC6 ACSL1 PTPRN DPP10 PCLO RFX6 GPR160 CADPS EPCAM | 2.12e-09 | 187 | 274 | 12 | a7d2f30fe0f19e63d44603ece9890acd11b45e52 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | NCAM2 RYR2 PTPRS FRAS1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 CNTN3 CDH11 | 3.03e-09 | 193 | 274 | 12 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | NCAM2 RYR2 PTPRS DLG2 COL14A1 FN1 LAMA4 EMILIN1 ADAMTS12 HMCN1 SUGCT CDH11 | 3.82e-09 | 197 | 274 | 12 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | RYR2 COL14A1 ADGRA3 FRAS1 COL12A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 CNTN3 CDH11 | 4.28e-09 | 199 | 274 | 12 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | NCAM2 RYR2 PTPRS MXRA5 FN1 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.28e-09 | 199 | 274 | 12 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL14A1 FGFR2 NOVA1 FLNB MXRA5 COL12A1 FN1 TNC GPX3 LAMA4 EMILIN1 CDH11 | 4.28e-09 | 199 | 274 | 12 | d9d7f36b4b5592b7855448730044c90997b55499 |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | NCAM2 RYR2 PTPRS MXRA5 FN1 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.28e-09 | 199 | 274 | 12 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IL16 NCAM2 RYR2 PTPRS COL14A1 NOVA1 FN1 GPX3 LAMA4 ADAMTS12 HMCN1 CDH11 | 4.53e-09 | 200 | 274 | 12 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | NCAM2 RYR2 COL14A1 FRAS1 MXRA5 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 FEZ1 CDH11 | 4.53e-09 | 200 | 274 | 12 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ANKRD13B PDGFRL PTPRN MXRA5 COL12A1 FN1 TNC EMILIN1 ADAMTS12 HMCN1 CDH11 | 1.66e-08 | 180 | 274 | 11 | 935c091bbcd6d10b81dc4731779e5bd98205c99f |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ANKRD13B PDGFRL PTPRN MXRA5 COL12A1 FN1 TNC EMILIN1 ADAMTS12 HMCN1 CDH11 | 1.66e-08 | 180 | 274 | 11 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CNTNAP3B PRODH2 RHOBTB1 DLG2 MTARC2 FGFR3 SLC5A10 PCLO GPX3 SUGCT TENM1 | 1.97e-08 | 183 | 274 | 11 | facd6dbe0851b537d70a899ac7485714ab27d071 |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | NCAM2 RYR2 DLG2 FRAS1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 3.23e-08 | 192 | 274 | 11 | 62904f94dfce430456f05066522cbf9bd29f4d7e |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PTPRS COL14A1 FN1 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 FEZ1 CDH11 | 3.60e-08 | 194 | 274 | 11 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | NCAM2 RYR2 FN1 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 LPL CNTN3 CDH11 | 3.60e-08 | 194 | 274 | 11 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | NCAM2 RYR2 PTPRS DLG2 FRAS1 FN1 GPX3 LAMA4 ADAMTS12 HMCN1 CDH11 | 3.79e-08 | 195 | 274 | 11 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ACLY UGGT1 LMTK3 RHOBTB1 PTPRN PCLO RFX6 EMILIN1 CADPS PAXIP1 GAA | 3.79e-08 | 195 | 274 | 11 | bd8e24dd598990204998d1dd853ba7a53dc0107e |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ACLY UGGT1 ASH1L STXBP1 PTPRN DYNC1H1 PCLO ARFGEF1 RFX6 NCOR1 CADPS | 3.79e-08 | 195 | 274 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | NCAM2 RYR2 DLG2 COL14A1 MXRA5 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.00e-08 | 196 | 274 | 11 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 RYR2 PTPRS FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 FEZ1 CDH11 | 4.21e-08 | 197 | 274 | 11 | 13896ec65ccda0b928c91d41112dc01b480036b7 |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | GPR155 COL14A1 FGFR3 SLITRK6 FLNA FRAS1 MXRA5 TNC TGFB2 HMCN1 CDH11 | 4.21e-08 | 197 | 274 | 11 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | FLNA IL31RA MXRA5 COL12A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 SUGCT CDH11 | 4.43e-08 | 198 | 274 | 11 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | IL16 NCAM2 RYR2 PTPRS FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.43e-08 | 198 | 274 | 11 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | GPR155 COL14A1 FGFR3 SLITRK6 FLNA FRAS1 MXRA5 TNC TGFB2 HMCN1 CDH11 | 4.43e-08 | 198 | 274 | 11 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FNBP1L TTC6 CNTN6 FAT1 PIGR FGFR3 ALCAM FGFR2 FLNB FRAS1 CNTN3 | 4.43e-08 | 198 | 274 | 11 | 1408e02e053ad3406229bfe8189da03be6366e81 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | NCAM2 EXT1 RYR2 COL14A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.43e-08 | 198 | 274 | 11 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | FLNA IL31RA MXRA5 COL12A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 SUGCT CDH11 | 4.43e-08 | 198 | 274 | 11 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL14A1 NOVA1 FLNB MXRA5 COL12A1 FN1 TNC GPX3 LAMA4 EMILIN1 CDH11 | 4.67e-08 | 199 | 274 | 11 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | NCAM2 RYR2 PTPRS COL14A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.67e-08 | 199 | 274 | 11 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | NCAM2 PTPRN COL14A1 MXRA5 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 FEZ1 CDH11 | 4.67e-08 | 199 | 274 | 11 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | FGFR2 SLITRK6 NOVA1 FLNB MXRA5 COL12A1 FN1 TNC GPX3 EMILIN1 CDH11 | 4.67e-08 | 199 | 274 | 11 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | NCAM2 RYR2 PTPRS FRAS1 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.91e-08 | 200 | 274 | 11 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | NCAM2 RYR2 PTPRS FRAS1 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.91e-08 | 200 | 274 | 11 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IL16 NCAM2 RYR2 PTPRS COL14A1 FN1 GPX3 LAMA4 ADAMTS12 HMCN1 CDH11 | 4.91e-08 | 200 | 274 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IL16 NCAM2 RYR2 PTPRS FRAS1 FN1 GPX3 LAMA4 ADAMTS12 HMCN1 CDH11 | 4.91e-08 | 200 | 274 | 11 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IL16 NCAM2 RYR2 PTPRS COL14A1 NOVA1 FN1 LAMA4 ADAMTS12 HMCN1 CDH11 | 4.91e-08 | 200 | 274 | 11 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | IL16 NCAM2 RYR2 PTPRS COL14A1 FN1 GPX3 LAMA4 ADAMTS12 HMCN1 CDH11 | 4.91e-08 | 200 | 274 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | PDGFRL COL14A1 MXRA5 COL12A1 FN1 TNC EMILIN1 ADAMTS12 HMCN1 SUGCT CDH11 | 4.91e-08 | 200 | 274 | 11 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NCAM2 RYR2 PTPRS FRAS1 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.91e-08 | 200 | 274 | 11 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | ERV3-1 RYR2 PTPRS FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 5.72e-08 | 159 | 274 | 10 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-08 | 162 | 274 | 10 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | DCHS2 KLHL28 ADAM9 COL14A1 MTARC2 FN1 PCDHGA9 CNTN3 CDH11 VPS13B | 8.59e-08 | 166 | 274 | 10 | 65dafed953b01a9830b54309af75c7a561e88336 |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-07 | 177 | 274 | 10 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-07 | 177 | 274 | 10 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-07 | 178 | 274 | 10 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-07 | 181 | 274 | 10 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-07 | 181 | 274 | 10 | af031661af28f99d906d8e013b4949133b44a2e6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PTPRH PCDH10 MMP19 COL12A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 CDH11 | 1.93e-07 | 181 | 274 | 10 | c62b0a2422377ffadaab63edd538e87a06fa5017 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PTPRH PCDH10 MMP19 COL12A1 FN1 TNC LAMA4 EMILIN1 ADAMTS12 CDH11 | 1.93e-07 | 181 | 274 | 10 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PDGFRL DLG2 COL14A1 CNGA3 NOVA1 COL12A1 FN1 TNC EMILIN1 HMCN1 | 2.03e-07 | 182 | 274 | 10 | 3dfa9187e9d2bab1d199079d29209c4648220ada |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CNTNAP3B PRODH2 RHOBTB1 DLG2 FGFR3 A1CF SLC5A10 PCLO SUGCT TENM1 | 2.14e-07 | 183 | 274 | 10 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDGFRL PTPRN MXRA5 COL12A1 FN1 TNC EMILIN1 ADAMTS12 HMCN1 CDH11 | 2.14e-07 | 183 | 274 | 10 | 803376f5260de83c48d4f7301278d078a32b3e6e |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDGFRL PTPRN MXRA5 COL12A1 FN1 TNC EMILIN1 ADAMTS12 HMCN1 CDH11 | 2.14e-07 | 183 | 274 | 10 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDGFRL PTPRN MXRA5 COL12A1 FN1 TNC EMILIN1 ADAMTS12 HMCN1 CDH11 | 2.14e-07 | 183 | 274 | 10 | cc7f5a17b40e8d901885174922e5fa8877643071 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDGFRL PTPRN COL14A1 MXRA5 FN1 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 2.36e-07 | 185 | 274 | 10 | 87c416d14ca6255bee39b16e7571553e36ee3069 |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GALNT13 PRODH2 PTPRN NOVA1 ARSJ DPP10 PCLO RFX6 GPR160 CADPS | 2.36e-07 | 185 | 274 | 10 | eb78614c4acf8d2ce7874d7e51e16997b76127ef |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ADAM9 EXT1 HMGCS1 COL14A1 SLITRK6 FN1 LAMA4 ADAMTS12 SUGCT CDH11 | 2.61e-07 | 187 | 274 | 10 | a9316e2818217ec5feae9cf8816f7249803caee6 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.61e-07 | 187 | 274 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-07 | 188 | 274 | 10 | ed074572e61d97c139fb1636a78c9b71e2c44ce0 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.88e-07 | 189 | 274 | 10 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-07 | 189 | 274 | 10 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RYR2 PTPRS COL14A1 MTARC2 MMP19 TNC GPX3 LAMA4 EMILIN1 CDH11 | 2.88e-07 | 189 | 274 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-07 | 190 | 274 | 10 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.17e-07 | 191 | 274 | 10 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.17e-07 | 191 | 274 | 10 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | FAT1 MXRA5 COL12A1 FN1 LAMA4 EMILIN1 ADAMTS12 HMCN1 SUGCT CDH11 | 3.33e-07 | 192 | 274 | 10 | 67e845e513e76e820f55e2f0d15eb16f2944d05c |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | CNTNAP3 COL14A1 FGFR3 FRAS1 MXRA5 COL12A1 LAMA4 HMCN1 LPL CDH11 | 3.49e-07 | 193 | 274 | 10 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | CNTNAP3 COL14A1 FGFR3 FRAS1 MXRA5 COL12A1 LAMA4 HMCN1 LPL CDH11 | 3.49e-07 | 193 | 274 | 10 | e4ea7ce011a80b81b841c907719aa532bed39d2e |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | CNTNAP3 COL14A1 FGFR3 FRAS1 MXRA5 COL12A1 LAMA4 HMCN1 LPL CDH11 | 3.49e-07 | 193 | 274 | 10 | cf2461af78f65616ce40d552ee9452295e3895ed |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.49e-07 | 193 | 274 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.49e-07 | 193 | 274 | 10 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.49e-07 | 193 | 274 | 10 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | FAT1 MXRA5 COL12A1 FN1 LAMA4 EMILIN1 ADAMTS12 HMCN1 SUGCT CDH11 | 3.49e-07 | 193 | 274 | 10 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Cbln1_(Layer_5a,_entorhinal_cortex_,_Cbln1+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.66e-07 | 74 | 274 | 7 | 0be24b07a2503a16ece1489e765200be4c7253cc | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | OBSCN RYR2 FAT1 MXRA5 COL12A1 LAMA4 EMILIN1 ADAMTS12 SUGCT CDH11 | 3.66e-07 | 194 | 274 | 10 | 2d66091097e106c7bee22e5281f50724700bdf8d |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NLRP11 KCNH7 PTPRN NOVA1 SLC2A8 PARP3 RFX6 GPRC6A DZANK1 CADPS | 3.66e-07 | 194 | 274 | 10 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | NCAM2 RYR2 MXRA5 FN1 LAMA4 EMILIN1 ADAMTS12 HMCN1 SUGCT CDH11 | 3.66e-07 | 194 | 274 | 10 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PTPRS DLG2 COL14A1 MTARC2 TNC GPX3 LAMA4 EMILIN1 ADAMTS12 CDH11 | 3.66e-07 | 194 | 274 | 10 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | NCAM2 RYR2 FRAS1 FN1 LAMA4 EMILIN1 ADAMTS12 HMCN1 CNTN3 CDH11 | 3.66e-07 | 194 | 274 | 10 | 35f132cc38ac133be01834ed0946188aa0757eb4 |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-07 | 194 | 274 | 10 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-07 | 194 | 274 | 10 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | EXT1 SHC3 COL14A1 FLNA COL12A1 TNC LAMA4 ADAMTS12 DCBLD2 CDH11 | 3.84e-07 | 195 | 274 | 10 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | EXT1 SHC3 COL14A1 FLNA COL12A1 TNC LAMA4 ADAMTS12 DCBLD2 CDH11 | 3.84e-07 | 195 | 274 | 10 | 4f70157d42a16ff0259bc24a62803c4df4285c44 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ACLY UGGT1 ASH1L PTPRN DYNC1H1 PCLO ARFGEF1 RFX6 NCOR1 CADPS | 3.84e-07 | 195 | 274 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 RYR2 PTPRS FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 3.84e-07 | 195 | 274 | 10 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | IL16 NCAM2 RYR2 PTPRS FN1 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 3.84e-07 | 195 | 274 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 RYR2 PTPRS FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 3.84e-07 | 195 | 274 | 10 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | NCAM2 RYR2 COL14A1 MXRA5 TNC LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.03e-07 | 196 | 274 | 10 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | IL16 NCAM2 RYR2 PTPRS COL14A1 FN1 LAMA4 ADAMTS12 HMCN1 CDH11 | 4.03e-07 | 196 | 274 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 RYR2 PTPRS FN1 GPX3 LAMA4 EMILIN1 ADAMTS12 HMCN1 CDH11 | 4.03e-07 | 196 | 274 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.54e-05 | 50 | 176 | 7 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Drug | beta-methyllanthionine | 1.67e-06 | 3 | 271 | 3 | CID000191096 | |
| Drug | AC1NRB2N | 2.36e-06 | 9 | 271 | 4 | CID000445220 | |
| Drug | LMWH | ACLY ADAM9 EXT1 RYR2 PHKA2 COL14A1 C4BPA FGFR3 FGFR2 AMPD1 COL12A1 FN1 TNC ARFGEF1 LAMA4 FNDC3A PRPF8 POLR3B NUDT6 LPL PES1 TNF SERPINA5 | 5.06e-06 | 663 | 271 | 23 | CID000000772 |
| Drug | SF-6,5 | 6.61e-06 | 4 | 271 | 3 | CID000126860 | |
| Disease | Ventricular Dysfunction | 3.84e-05 | 8 | 264 | 3 | C0242973 | |
| Disease | Metabolic myopathy | 7.97e-05 | 2 | 264 | 2 | cv:C0270984 | |
| Disease | Isolated coronal synostosis | 7.97e-05 | 2 | 264 | 2 | cv:CN043619 | |
| Disease | developmental and epileptic encephalopathy 64 (implicated_via_orthology) | 7.97e-05 | 2 | 264 | 2 | DOID:0070375 (implicated_via_orthology) | |
| Disease | Crohn Disease | 8.42e-05 | 50 | 264 | 5 | C0010346 | |
| Disease | craniosynostosis (is_implicated_in) | 1.47e-04 | 12 | 264 | 3 | DOID:2340 (is_implicated_in) | |
| Disease | Cardiomyopathies | 1.76e-04 | 130 | 264 | 7 | C0878544 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.38e-04 | 3 | 264 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | Saethre-Chotzen Syndrome | 2.38e-04 | 3 | 264 | 2 | C0175699 | |
| Disease | Congenital hypoplasia of radius | 2.38e-04 | 3 | 264 | 2 | C0685381 | |
| Disease | Lacrimoauriculodentodigital syndrome | 2.38e-04 | 3 | 264 | 2 | C0265269 | |
| Disease | muscular dystrophy (is_marker_for) | 2.38e-04 | 3 | 264 | 2 | DOID:9884 (is_marker_for) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.38e-04 | 3 | 264 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Levy-Hollister syndrome | 2.38e-04 | 3 | 264 | 2 | cv:C0265269 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.38e-04 | 181 | 264 | 8 | DOID:684 (is_implicated_in) | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 4.39e-04 | 17 | 264 | 3 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Malignant mesothelioma | 4.55e-04 | 109 | 264 | 6 | C0345967 | |
| Disease | FG syndrome | 4.73e-04 | 4 | 264 | 2 | cv:C0220769 | |
| Disease | TWIST1-related craniosynostosis | 4.73e-04 | 4 | 264 | 2 | cv:C4551902 | |
| Disease | reticulocyte count | EPRS1 ENKUR ACLY ASH1L EHD4 FAT1 CCM2 PTPRH PTPRN C4BPA HSP90AB1 FLNB FNTB LAMA4 NOL9 PRPF8 EEF1B2 LPL EIF2AK4 ARHGAP45 GAA | 5.10e-04 | 1045 | 264 | 21 | EFO_0007986 |
| Disease | Endometrioma | 6.42e-04 | 161 | 264 | 7 | C0269102 | |
| Disease | Endometriosis | 6.42e-04 | 161 | 264 | 7 | C0014175 | |
| Disease | Disproportionate short stature | 6.45e-04 | 77 | 264 | 5 | C0878659 | |
| Disease | Disorder of eye | 6.82e-04 | 212 | 264 | 8 | C0015397 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.99e-04 | 45 | 264 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | lymphocyte count | IL16 CDH23 SMYD2 PTPRH SCGB1C2 XPO6 TMEM38A ZNF638 AP1M1 PLEC NUP160 SCGB1C1 FLNB FRAS1 IL31RA FN1 PCDHGA9 NUP88 TDRD1 NCOR1 RHOH SLC9A4 GATAD1 TNF ARHGAP45 FAM177A1 | 7.26e-04 | 1464 | 264 | 26 | EFO_0004587 |
| Disease | nasal type extranodal NK/T-cell lymphoma (is_marker_for) | 7.83e-04 | 5 | 264 | 2 | DOID:0080797 (is_marker_for) | |
| Disease | bone disease (implicated_via_orthology) | 7.83e-04 | 5 | 264 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 9.67e-04 | 49 | 264 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | vitronectin measurement | 1.10e-03 | 23 | 264 | 3 | EFO_0021843 | |
| Disease | iron deficiency anemia (is_implicated_in) | 1.17e-03 | 6 | 264 | 2 | DOID:11758 (is_implicated_in) | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 1.41e-03 | 25 | 264 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.60e-03 | 56 | 264 | 4 | EFO_0022279 | |
| Disease | Urogenital Abnormalities | 1.63e-03 | 7 | 264 | 2 | C0042063 | |
| Disease | peritonitis (biomarker_via_orthology) | 1.63e-03 | 7 | 264 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | Craniosynostosis syndrome | 1.63e-03 | 7 | 264 | 2 | cv:C0010278 | |
| Disease | Usher syndrome | 1.63e-03 | 7 | 264 | 2 | cv:C0271097 | |
| Disease | Constipation | 1.63e-03 | 7 | 264 | 2 | C0009806 | |
| Disease | Hypertrophic Cardiomyopathy | 1.71e-03 | 57 | 264 | 4 | C0007194 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.77e-03 | 27 | 264 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Liver neoplasms | 1.80e-03 | 142 | 264 | 6 | C0023903 | |
| Disease | Malignant neoplasm of liver | 1.80e-03 | 142 | 264 | 6 | C0345904 | |
| Disease | hearing impairment | 1.91e-03 | 98 | 264 | 5 | C1384666 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.94e-03 | 59 | 264 | 4 | EFO_0022260 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 2.06e-03 | 60 | 264 | 4 | EFO_0021898 | |
| Disease | dual specificity protein phosphatase 13 isoform A measurement | 2.15e-03 | 8 | 264 | 2 | EFO_0801549 | |
| Disease | neutropenia (is_implicated_in) | 2.15e-03 | 8 | 264 | 2 | DOID:1227 (is_implicated_in) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.15e-03 | 8 | 264 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | testis-expressed sequence 29 protein measurement | 2.15e-03 | 8 | 264 | 2 | EFO_0802125 | |
| Disease | lactase-phlorizin hydrolase measurement | 2.15e-03 | 8 | 264 | 2 | EFO_0801753 | |
| Disease | Cone-Rod Dystrophy 2 | 2.18e-03 | 29 | 264 | 3 | C3489532 | |
| Disease | 1,5 anhydroglucitol measurement | 2.18e-03 | 29 | 264 | 3 | EFO_0008009 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 2.33e-03 | 62 | 264 | 4 | EFO_0022306 | |
| Disease | free cholesterol in very large HDL measurement | 2.33e-03 | 62 | 264 | 4 | EFO_0022273 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 2.33e-03 | 62 | 264 | 4 | EFO_0022263 | |
| Disease | right ventricular ejection fraction measurement | 2.40e-03 | 30 | 264 | 3 | EFO_0021816 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 2.47e-03 | 63 | 264 | 4 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.47e-03 | 63 | 264 | 4 | EFO_0022292 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | DCDC1 CDH23 NCAM2 MDGA2 SHC3 RYR2 SMYD2 DLG2 ALCAM USH2A FLII NRAP LRPPRC TTL CNTN3 CDH8 | 2.48e-03 | 801 | 264 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | cognitive function measurement | EFCAB5 KCNH7 SGSM1 NCAM2 MDGA2 EXT1 ZNF804A ZNF638 LRRC7 USH2A ADGRA3 NOVA1 A1CF ARSJ RFX6 EDEM3 LRPPRC SLC9A4 TTLL2 PAXIP1 HARS1 PACRG MUC2 CDH8 | 2.53e-03 | 1434 | 264 | 24 | EFO_0008354 |
| Disease | BMI-adjusted waist circumference, forced expiratory volume | 2.75e-03 | 9 | 264 | 2 | EFO_0004314, EFO_0007789 | |
| Disease | Headache, glucose measurement | 2.75e-03 | 9 | 264 | 2 | EFO_0004468, HP_0002315 | |
| Disease | alpha-1-antitrypsin measurement | 2.75e-03 | 9 | 264 | 2 | EFO_0008327 | |
| Disease | ulcerative colitis (biomarker_via_orthology) | 2.75e-03 | 9 | 264 | 2 | DOID:8577 (biomarker_via_orthology) | |
| Disease | total lipids in very large HDL measurement | 2.92e-03 | 66 | 264 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 2.92e-03 | 66 | 264 | 4 | EFO_0022298 | |
| Disease | asthma (is_implicated_in) | 2.97e-03 | 157 | 264 | 6 | DOID:2841 (is_implicated_in) | |
| Disease | reticulocyte measurement | ENKUR ASH1L EHD4 FAT1 CCM2 PTPRH C4BPA FLNA FLNB FNTB NOL9 PRPF8 AZIN1 DNAJA3 EEF1B2 LPL EIF2AK4 ARHGAP45 GAA | 3.15e-03 | 1053 | 264 | 19 | EFO_0010700 |
| Disease | sensorineural hearing loss (is_implicated_in) | 3.17e-03 | 33 | 264 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | internet addiction disorder | 3.17e-03 | 33 | 264 | 3 | EFO_0803368 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.26e-03 | 160 | 264 | 6 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Graves ophthalmopathy (is_implicated_in) | 3.42e-03 | 10 | 264 | 2 | DOID:0081120 (is_implicated_in) | |
| Disease | anemia (is_marker_for) | 3.42e-03 | 10 | 264 | 2 | DOID:2355 (is_marker_for) | |
| Disease | cholesterol in very large HDL measurement | 3.43e-03 | 69 | 264 | 4 | EFO_0022229 | |
| Disease | stroke outcome severity measurement | 3.67e-03 | 114 | 264 | 5 | EFO_0009603 | |
| Disease | ocular sarcoidosis | 3.95e-03 | 116 | 264 | 5 | EFO_0010723 | |
| Disease | interleukin 4 measurement | 4.07e-03 | 36 | 264 | 3 | EFO_0008184 | |
| Disease | Diabetic Cardiomyopathies | 4.16e-03 | 11 | 264 | 2 | C0853897 | |
| Disease | Aortic Valve Insufficiency | 4.16e-03 | 11 | 264 | 2 | C0003504 | |
| Disease | Complications of Diabetes Mellitus | 4.16e-03 | 11 | 264 | 2 | C0342257 | |
| Disease | tuberculosis (is_marker_for) | 4.16e-03 | 11 | 264 | 2 | DOID:399 (is_marker_for) | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 4.16e-03 | 11 | 264 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | Hyperhomocysteinemia | 4.16e-03 | 11 | 264 | 2 | C0598608 | |
| Disease | Colorectal Carcinoma | PDGFRL OBSCN ZNF804A TXNRD1 FAT1 PTPRS PAN2 FGFR3 ALDH2 AMPD1 FN1 ARFGEF1 TENM1 TNF | 4.60e-03 | 702 | 264 | 14 | C0009402 |
| Disease | colorectal cancer (is_implicated_in) | 4.73e-03 | 121 | 264 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | phosphatidylethanolamine measurement | 4.78e-03 | 173 | 264 | 6 | EFO_0010228 | |
| Disease | open-angle glaucoma (is_implicated_in) | 4.96e-03 | 12 | 264 | 2 | DOID:1067 (is_implicated_in) | |
| Disease | Spina Bifida | 4.96e-03 | 12 | 264 | 2 | C0080178 | |
| Disease | Status Dysraphicus | 4.96e-03 | 12 | 264 | 2 | C0038219 | |
| Disease | liver disease (is_implicated_in) | 4.96e-03 | 12 | 264 | 2 | DOID:409 (is_implicated_in) | |
| Disease | Abruptio Placentae | 4.96e-03 | 12 | 264 | 2 | EFO_1001754 | |
| Disease | Rachischisis | 4.96e-03 | 12 | 264 | 2 | C0266508 | |
| Disease | lifestyle measurement | 5.43e-03 | 235 | 264 | 7 | EFO_0010724 | |
| Disease | Lymphoma | 5.48e-03 | 40 | 264 | 3 | C0024299 | |
| Disease | Asthma | 5.82e-03 | 80 | 264 | 4 | C0004096 | |
| Disease | salicylurate measurement | 5.83e-03 | 13 | 264 | 2 | EFO_0010532 | |
| Disease | diabetic angiopathy (is_implicated_in) | 5.83e-03 | 13 | 264 | 2 | DOID:11713 (is_implicated_in) | |
| Disease | uveitis (is_implicated_in) | 5.83e-03 | 13 | 264 | 2 | DOID:13141 (is_implicated_in) | |
| Disease | Hyperlipoproteinemia Type IIb | 5.83e-03 | 13 | 264 | 2 | C1704417 | |
| Disease | Carcinoma, Transitional Cell | 5.87e-03 | 41 | 264 | 3 | C0007138 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPYQAFKTKDGYIVV | 276 | Q9HAC7 | |
| PGDFYVQLYSSEVLE | 276 | Q9BXT4 | |
| TLYPAVKSLLQEGIY | 1461 | Q14146 | |
| AVYYDSPGIVNILLK | 206 | Q5TYW2 | |
| PTKEDVYVVGTVLRY | 316 | P04003 | |
| LKQGEALGYPIYDET | 451 | Q14264 | |
| DLDPGQTLIYYVDEK | 241 | P16422 | |
| VYVDVKPLSGYEATT | 2081 | Q9NR48 | |
| QPLVAVLIDSGDTYY | 476 | Q9BZ76 | |
| EAYGLDPYSVAAILQ | 511 | P41214 | |
| LYEGESTVYPVFINE | 271 | Q96HD9 | |
| IVYPENTGLYVIVES | 611 | Q5SY80 | |
| NTGLYVIVESYGPKI | 616 | Q5SY80 | |
| PEDKLSQVYIILYDA | 1216 | Q9P2K8 | |
| YPGIDLSQVYDLLEK | 486 | P42684 | |
| KTYAAEYTLQTLGIP | 511 | Q9NQ94 | |
| VKIISEPGSYYVSSA | 266 | O14977 | |
| PLYDTLGNEAITYIV | 176 | P33121 | |
| AYEINAITGVKPYFT | 226 | Q8WW27 | |
| AVYYDSPGIVNILLK | 206 | Q4UJ75 | |
| YSPNIALEAYVIKST | 536 | Q8IWK6 | |
| PEEYLSAIYNEIAGK | 866 | Q9Y6D6 | |
| VLVKFDTQYPYGEKQ | 56 | P30040 | |
| LTIDGEEYIPFKQYA | 46 | P22352 | |
| IPAATTIAYGVIELY | 211 | O60443 | |
| VYDGKKNIYTVTALP | 91 | Q9UL18 | |
| NGDYTYVERVKIPLD | 226 | Q96Q83 | |
| SQAKVIYGLEPIFES | 1626 | Q96L96 | |
| GYPQTTDSKILQEYI | 121 | Q9BXS5 | |
| EVKYLGQLTSIPGYL | 66 | Q9BSQ5 | |
| KDGVVYVYPNEAAVS | 211 | P23109 | |
| LTEPLAIVEGYNSYF | 56 | Q9UBZ4 | |
| LYLALQVYGVEVPAE | 196 | Q8N1B3 | |
| TYYDVLGVKPNATQE | 6 | P31689 | |
| PDVYGEKGLEIVYNV | 86 | P51164 | |
| IPLRSNVYEVYATDK | 2626 | Q9H251 | |
| SVSPDLKYVLLAYDV | 131 | Q8N608 | |
| VTNPGIKYEYTIQKD | 801 | P58397 | |
| DVGIVALEIYFPSQY | 16 | Q01581 | |
| VVYKSIPYGSLEEVI | 481 | Q9UF12 | |
| ATKPISVSDYVPYVN | 931 | Q9HBD1 | |
| EDVIYPTRTKGVAYV | 51 | Q6ZSC3 | |
| VTVPKDLYVVEYGSN | 21 | Q9NZQ7 | |
| GENAFINIKYVVPTY | 276 | Q96M98 | |
| GLLVYPEETVYLAAE | 36 | Q8HWS3 | |
| PVSAEDKSYRIIYNL | 466 | Q7Z3E1 | |
| SGAPEYKVIQTYLEQ | 331 | Q9Y6F1 | |
| NYASVKTPALIVYGD | 146 | Q96IU4 | |
| AVYYDSPGIVNILLK | 206 | Q5SQ80 | |
| YEAKVYGASNVELIT | 271 | Q86YJ7 | |
| VKYYAVGDIDPQVIQ | 16 | Q6ZW49 | |
| PQELLQLDGYTVDYT | 566 | Q9ULU8 | |
| DKYTLNITVYDLGIP | 786 | Q14517 | |
| QDGPLYVIVEYASKG | 556 | P21802 | |
| IEGTVPYVTTDYNFK | 656 | Q5SY16 | |
| VDYLTQYSGIKPGDL | 1036 | Q504Q3 | |
| TLDGNTVNPIYKYIL | 36 | M0R2J8 | |
| SQFIGYPITLYLEKE | 206 | P08238 | |
| AVDVDSGSVYDIYLP | 1096 | O95819 | |
| YGYIVTDQKPLSLAA | 471 | Q16849 | |
| GYLELPQINYKLSVE | 736 | Q13045 | |
| IYKITQDYPQFGEVV | 1366 | Q86XX4 | |
| VVQVPYLEAGEAVVY | 996 | Q92619 | |
| IASVLGISTPKYQYA | 121 | Q8N128 | |
| TPVLYEGVDEVKAYI | 716 | Q2M2H8 | |
| YGVYPAEKISCIDQI | 11 | Q86VF7 | |
| SLYSVPEGQSKYVEE | 41 | Q9BUR5 | |
| VGEPYSIQAYAKEGV | 406 | Q8NI17 | |
| DEIDIGTYKVYNIPL | 951 | Q96NW7 | |
| ELANVLPISYEGQYI | 51 | P59045 | |
| DFALGYPIVEALYQT | 146 | Q7Z3F1 | |
| YAIGNVERPYLTDKI | 571 | Q9NS40 | |
| QFIGYPITLYLEKEQ | 186 | Q58FF7 | |
| LAAEGVKLENYYVQP | 106 | Q5FYB0 | |
| ISSIADYYGIKQVID | 166 | Q8N6Q8 | |
| ATGDPYYLEVGKTLI | 416 | Q9BZQ6 | |
| KVILGEIFSDYTPAQ | 146 | Q96Q04 | |
| PILYSFYLDEKIVGN | 236 | Q6DN72 | |
| ATVTSILYPAITKYE | 521 | Q5CZC0 | |
| SYIAQEPGNYEVSIK | 2251 | O75369 | |
| TTLYLEPKITSNYEV | 3966 | Q9Y6V0 | |
| SQPVLKPLEYSQYEV | 1111 | Q9H6A9 | |
| KPLEYSQYEVRGAAQ | 1116 | Q9H6A9 | |
| YILNVTVYDLGTPQK | 786 | Q9NYQ8 | |
| GPYGTIDYTIINKLA | 2511 | Q9NYQ8 | |
| YPVSAGYTKLVGQDV | 121 | P06858 | |
| LGLAEVAPVDYLSQY | 21 | Q99542 | |
| LAYADTLPNVVYGLT | 186 | Q9H255 | |
| YGYIVSAVLKIPSAE | 221 | Q8NGJ0 | |
| VEELPAVYTGLFYKL | 286 | P53370 | |
| IRYSVPEETEKGYIV | 31 | Q9Y5G4 | |
| NYVVDIPELGVLVSY | 4586 | Q02817 | |
| TAGSLESTEPIYVYK | 666 | Q6P996 | |
| ESTEPIYVYKAQGAG | 671 | Q6P996 | |
| DSIYGPIGIYVKTIF | 236 | Q14005 | |
| KEEYGDIPIYITENG | 1261 | P09848 | |
| YPNAAIIAKIADYGI | 2006 | Q5S007 | |
| GYPQYVSEILEKVTC | 316 | P42704 | |
| SENKVIEPQYFGLAY | 1206 | P42704 | |
| YDELFYTLSPINGKI | 451 | Q9H223 | |
| GTDKQYLNTVIPYEK | 336 | Q99689 | |
| TPYLDLNLETGVLYV | 61 | Q9P2E7 | |
| DVGVYIKDLSAYVVN | 176 | Q9Y496 | |
| TDVTQTFGIEKYIPY | 471 | Q04756 | |
| KGTLYIVEQIPTYVE | 371 | Q6P4A8 | |
| TYNLTELIKPEAYEV | 701 | Q7Z553 | |
| YTAEPYGELILENVV | 4216 | Q96RW7 | |
| YAVVSVGDPVYIITE | 251 | Q13882 | |
| LYAYIQKLAQVEPGE | 1661 | Q13332 | |
| EENTGVLYLIKPLDY | 2716 | Q6V1P9 | |
| IYATTFGKYVPAVEI | 801 | Q5T6X5 | |
| YIISPGVVKVDYGDV | 381 | Q8IUC8 | |
| LAYVLGDPAIYQSLK | 151 | Q9UJ42 | |
| IFDIYVVTADYLPLG | 5601 | Q5VST9 | |
| DQDKVYSLFYTIIIP | 271 | Q9NZP5 | |
| LVTPYIPKAEAYESV | 246 | C9JE40 | |
| GNPVEIDTYTYECIK | 441 | Q9Y236 | |
| YLYAVIADVTSISPK | 231 | P47804 | |
| VYPDINIITGALKLY | 341 | P52757 | |
| DIPYKVLKYTAGEIN | 3866 | Q9P2D7 | |
| STKYGEPITSEYIEV | 681 | A4FU69 | |
| AVYYDSPGIVNILLK | 206 | Q5VUR7 | |
| EDIINYTEPKLGYTR | 2501 | Q9ULT8 | |
| EGYKTPYTDVNIVTI | 131 | P50213 | |
| VLSVGADQYLLPKDY | 366 | Q8NB78 | |
| GQSYLQSVEKYIPKI | 396 | Q9NXS3 | |
| EVPATITYIKDGQRY | 186 | Q9BX69 | |
| YKVPLNGQVYELLTV | 346 | Q96M89 | |
| TGGLYETVNEVYKLV | 1741 | Q8NF50 | |
| EGYVPTSYIDVTLEK | 586 | Q5T0N5 | |
| VYVYPQQKGEKIAES | 116 | Q16394 | |
| SVIDEQDGKPYYAQI | 156 | Q8WUU5 | |
| LKPETLYLVNVTAEY | 691 | Q99715 | |
| VKQYLVTYTPVAGGE | 841 | Q99715 | |
| YTILIKYGGDEIPFS | 1616 | P21333 | |
| AYVVQEPGDYEVSVK | 2296 | P21333 | |
| ISGLKPGVDYTITVY | 1596 | P02751 | |
| ITGLEPGTEYTIYVI | 2051 | P02751 | |
| PGTEYTIYVIALKNN | 2056 | P02751 | |
| DTEYKVTVTPIYTDG | 801 | Q05707 | |
| GLQPDSEYKISVYTK | 976 | Q05707 | |
| SVPELYGYEVLISST | 301 | Q9Y2H6 | |
| KYQKPIIQSEYGAET | 531 | P08236 | |
| TTGTAYFEVKEYVLP | 211 | P01031 | |
| LYLPKFSIEGSYQLE | 301 | P05154 | |
| DYLVDTLGPYVINVT | 336 | O43820 | |
| NTTVVYIPDLNTGYK | 471 | Q5VWK5 | |
| KLVYSILEGQPYFSV | 196 | P55287 | |
| EVFGTYVPGYLLKLS | 506 | Q9Y653 | |
| PYSKQVSYVIQAEGK | 61 | Q13443 | |
| LYIAKVEPSDVGNYT | 181 | Q9UQ52 | |
| GPIYREKLGNVESVY | 86 | P05108 | |
| NGAVYLPSKELDYLI | 241 | Q6IMN6 | |
| VPCETLEYIEANYGK | 411 | O75072 | |
| YGVTPEYICKRNEEI | 151 | Q8TC29 | |
| PLFGIYYSVEKIGSL | 311 | Q969Z3 | |
| EPKSVVQQYLDVVGY | 346 | P10253 | |
| LKVYVRPTNETLYEA | 166 | O43921 | |
| YNIGPDKVIQATTYF | 401 | P49356 | |
| SYKLDPYVQRLAETV | 826 | Q14204 | |
| LDTIPYVNGTEIEYE | 81 | Q15700 | |
| YGTQYKQEAIPDEVI | 496 | P14735 | |
| SLYPVGYLDKQVPDT | 41 | Q5J8M3 | |
| VLEDGVETYVKYQPC | 71 | Q9Y6C2 | |
| VVISKGIPYYESSLA | 256 | Q96PD2 | |
| EQYEIEVTVISPGYI | 226 | Q6IAN0 | |
| DPVYGNSAKLVYSIL | 196 | P55286 | |
| TQGGPLYVLVEYAAK | 546 | P22607 | |
| DKSYIEGYVPSQADV | 21 | P24534 | |
| VNIYYTLDGSKPEFL | 41 | Q9NVP4 | |
| SAPLAKEDYYQILGV | 86 | Q96EY1 | |
| KEDYYQILGVPRNAS | 91 | Q96EY1 | |
| PLVALYLVYDTGDVS | 541 | Q8WUM9 | |
| IANGKELSTYYQVEP | 1521 | Q92736 | |
| NGRYYSKIIISPEEN | 466 | Q13740 | |
| YTGVIYEAVLLQTPA | 331 | P12081 | |
| IGKVYIDIDPLLYSE | 86 | Q86YS7 | |
| QVDLYIPKVTISGVY | 296 | P08185 | |
| LYISKVEPSDVGNYT | 181 | Q9P232 | |
| VESYTPQTQGKYEFI | 216 | P07358 | |
| EYIKAFGSTIVINPE | 496 | Q13620 | |
| PEGGDVLYSYTIITV | 186 | Q96FZ2 | |
| PSLEGVSEKQYTIYI | 351 | Q06587 | |
| QPLVAVLIDSGDTYY | 476 | Q96NU0 | |
| QADILYILYVIKGPS | 776 | P46019 | |
| KVLYEIPDTYAQTEG | 21 | Q9BU68 | |
| YVYNLGTKDVEIPLD | 906 | Q16363 | |
| EDGQYFLKVLIPSYA | 46 | P51513 | |
| QNGKDEVVAYPLYIL | 256 | Q99567 | |
| YSGIPEYVGVNITKL | 4226 | Q685J3 | |
| LYTLVNKVQYGIFPD | 126 | Q92552 | |
| IPLTIVKSDGGYTYD | 371 | P54136 | |
| IEEKYPIINYTFTSG | 206 | C9JL84 | |
| VTYKDGNQRYEALVP | 1731 | Q5TCS8 | |
| AKPTVQDLQGEVEYY | 2946 | O75445 | |
| TYPILGEKITQDTLY | 11 | Q8TED0 | |
| PDLTGYITEGQIYVD | 366 | P21281 | |
| YEIYGTINTKEVDPA | 386 | Q9H8W5 | |
| QYKSLIGVEYKPVSA | 941 | P07814 | |
| VLYAATVKNYLGTEP | 186 | O95754 | |
| YLEYNAIKEILPGTF | 441 | Q9H5Y7 | |
| INISPDGKYVYIAEL | 226 | P27169 | |
| ETLVQKVVSPYLGTY | 201 | P85299 | |
| VTKYIAGPYECEIRN | 206 | Q00889 | |
| EAYKPTVYENTGVDV | 31 | Q15669 | |
| EFLKTSEVPYAGINI | 996 | O60841 | |
| VASLVAPVYISEIAY | 136 | Q9NY64 | |
| VELPLYNQPSDTKVY | 261 | O75376 | |
| LVLYIYGAPQDVKAQ | 851 | P98174 | |
| YEALPIIYKNGDIVR | 66 | Q9NUX5 | |
| EVAKELGIPYYETSV | 176 | Q9BYZ6 | |
| TPEELYEGTLGKYNV | 41 | P0DMR2 | |
| KKYQDEYGVSSIIPN | 106 | Q8WVD3 | |
| GISVFELDYDYVQIP | 56 | Q6AI14 | |
| DQVLGPGVTYVVKYL | 146 | Q92529 | |
| REIVTSEGLKLYYNP | 336 | Q149N8 | |
| GQVIKEILYTPYGDI | 2331 | Q9UKZ4 | |
| NYPVGKIQDVAKYTT | 2411 | Q9UKZ4 | |
| YGEVEEVEILYNPKT | 126 | Q9UPS6 | |
| LTYEDNGYVVTKPKV | 121 | A8MV57 | |
| QYKSIYPTLEIDIEG | 201 | P30520 | |
| EVAKELGLPYYETSV | 176 | O94844 | |
| TLEYGKPQYTEADVI | 401 | Q5VTB9 | |
| ISVVDYSYLEGDLPI | 401 | Q5SWA1 | |
| ISVKYQLLYVAVPSG | 256 | Q15198 | |
| LLPIENDVYKYETSG | 256 | P61764 | |
| DGEIVSTPRLQYYDK | 951 | Q12769 | |
| YFTYLEINPLVVTKD | 196 | P53396 | |
| ALETLDNGKPYVISY | 121 | P05091 | |
| DNGKPYVISYLVDLD | 126 | P05091 | |
| SVPVSQKYELGAALY | 151 | O00501 | |
| LVPTDLAYLKVGTNY | 256 | Q16281 | |
| DIKETGYTYILPKNV | 2096 | Q6P2Q9 | |
| IIPYAGIDLAVYETL | 346 | Q6KCM7 | |
| GFLVIDTSPDIQIYY | 1586 | O75443 | |
| VSQDLEPLTILYYIG | 381 | P61812 | |
| VPYIYAIGDILEDKV | 476 | Q16881 | |
| QVFGPYYTEILKTLI | 476 | Q8WWU5 | |
| YYTEILKTLISPAQA | 481 | Q8WWU5 | |
| AYSVTQGTLEILYPD | 161 | Q86W33 | |
| EQYVPSEKLSIYGDL | 266 | Q9BXS4 | |
| ILEEEKIYAYPSNIT | 206 | Q8IY95 | |
| EYDVKYPALIPITTA | 111 | Q5BJH2 | |
| VQSYIVSGKDYPRVE | 211 | Q9H270 | |
| TLTKHQIIYTGEEPY | 236 | P52744 | |
| QYKYIVIEPTRIGDE | 56 | P17152 | |
| IAIDTDPKNYLAYEG | 306 | Q86TZ1 | |
| EDSPNKLYTLVTYVP | 96 | P62899 | |
| KGIYYQAEVLGQPIV | 186 | O00541 | |
| QDDGGAPILEYIVKY | 616 | O15394 | |
| EIVTLPEYIQKRYGG | 116 | A0PJK1 | |
| LSDPLYVLDQAVGAY | 651 | Q5K4L6 | |
| YVLDQAVGAYLPLTT | 656 | Q5K4L6 | |
| GTEYTCKVYPVQEAL | 91 | Q96RU7 | |
| PYLQGQVTLELAVYK | 276 | O15533 | |
| TQYDEIGIPVALLSY | 131 | Q8TCT7 | |
| VDSYVISYTGEKVPE | 1826 | P24821 | |
| SVYPGYGVEIKVQNI | 276 | Q53EL9 | |
| KYLNIYVGLPDVEES | 76 | Q9NW08 | |
| TPEELYEGTLGKYNV | 41 | Q8TD33 | |
| CVTGFKPLTIYVYQE | 261 | Q9BWV7 | |
| GVTYSPELLDLYTVN | 921 | Q2NKQ1 | |
| PLEVAYQRGYLNKDT | 3956 | Q15149 | |
| YKQIGLYPVLVIDSS | 166 | P01833 | |
| LGYSYAIDLPVSVEE | 451 | P40126 | |
| SGLVYKNVTVPVYTA | 461 | Q9ULM0 | |
| LVGDSVVLKQDSIYY | 381 | Q6UW63 | |
| TVLKQEYPEGVDVVY | 231 | Q8N4Q0 | |
| YEGGRYQLEIKIPET | 51 | P61086 | |
| LKLPGVYEVLFYNET | 2316 | Q7Z7G8 | |
| YQLGELVKVENYPEV | 341 | Q9UIA9 | |
| IPYAGIDLAVYETLK | 346 | Q9BV35 | |
| GYIPSYLDKDEQCVV | 41 | P10827 | |
| YDIALVKLSAPVTYT | 136 | Q9Y6M0 | |
| LPGVYQKLLDLYESV | 96 | Q6PGP7 | |
| GEPYTLNEESLYQKI | 196 | P17014 | |
| QEYGTRIGKTPVYDL | 36 | Q15633 | |
| YGSQIKLYNIETAVP | 596 | Q96QU8 | |
| KPGEEVFTSYIDLLY | 231 | Q9NRG4 | |
| YQLYVSLISAEVPLG | 186 | Q6PP77 | |
| KVEALEPGTLYNFTV | 631 | Q9HD43 | |
| ESYVIYPTNLKTPVA | 96 | Q8NG68 | |
| PITLGVILNSYYDVK | 136 | Q7Z769 | |
| IVSILYLKYEPGAVE | 31 | Q9H6F2 | |
| NLPNKGYSVEEVYDL | 911 | Q14966 | |
| DNQLVVPSEGLYLIY | 121 | P01375 | |
| VPSEGLYLIYSQVLF | 126 | P01375 | |
| KEPVYLSGYGVELAI | 236 | Q9NYU2 | |
| KYPYVEVNSILGIDS | 596 | Q9NYU2 | |
| YTENAGKYLLEPISE | 626 | Q7Z570 | |
| KTYLAVQVPYGDVVT | 2351 | Q9NR99 | |
| YTVVKGIISPVGDAY | 41 | Q9HAN9 |